Differential lidocaine sensitivity of human voltage-gated potassium channels relevant to the auditory system

Otology and Neurotology

Volumn 27, Issue 1, 2006, Pages 117-123

  Trellakis, Sokratis ^a,d   Benzenberg, Dietmar ^b   Urban, Bernd W ^b   Friederich, Patrick ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Auditory system; Lidocaine; Local anesthetics; Patch clamp; Processing of hearing; Tinnitus; Voltage dependent potassium channels

Indexed keywords

LIDOCAINE; VOLTAGE GATED POTASSIUM CHANNEL;

ANESTHESIA INDUCTION; ARTICLE; AUDITORY SYSTEM; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; EMBRYO; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IC 50; INHIBITION KINETICS; ION CONDUCTANCE; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TINNITUS;

ANESTHETICS, LOCAL; CELL CULTURE TECHNIQUES; CELL LINE; HEARING LOSS; HUMANS; LIDOCAINE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; TINNITUS; TUMOR CELLS, CULTURED;

EID: 29444453062     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000186443.11832.8a     Document Type: Article

References (46)

1. Grigg JJ, Brew HM, Tempel BL. Differential expression of voltage-gated potassium channel genes in auditory nuclei of the mouse brainstem. Hear Res 2000;140:77-90.
2. Li W, Kaczmarek LK, Perney TM. Localization of two high-threshold potassium channel subunits in the rat central auditory system. J Comp Neurol 2001;437:196-218.
3. Brew HM, Hallows JL, Tempel BL. Hyperexcitability and reduced low threshold potassium currents in auditory neurons of mice lacking the channel subunit Kv1.1. J Physiol 2003;548:1-20.
4. Bal R, Oertel D. Potassium currents in octopus cells of the mammalian cochlear nucleus. J Neurophysiol 2001;86:2299-311.
5. Mo ZL, Adamson CL, Davis RL. Dendrotoxin-sensitive K(+) currents contribute to accommodation in murine spiral ganglion neurons. J Physiol 2002;542:763-78.
6. Trussell LO. Synaptic mechanisms for coding timing in auditory neurons. Annu Rev Physiol 1999;61:477-96.
7. Kopp-Scheinpflug C, Fuchs K, Lippe WR, et al. Decreased temporal precision of auditory signaling in Kcna1-null mice: an electrophysiological study in vivo. J Neurosci 2003;23:9199-207.
8. Macica CM, von Hehn CA, Wang LY, et al. Modulation of the Kv3.1b potassium channel isoform adjusts the fidelity of the firing pattern of auditory neurons. J Neurosci 2003;23:1133-41.
9. Liu SQ, Kaczmarek LK. Aminoglycosides block the Kv3.1 potassium channel and reduce the ability of inferior colliculus neurons to fire at high frequencies. J Neurobiol 2004;62:439-52.
10. Leao RN, Berntson A, Forsythe ID, et al. Reduced low-voltage activated K+ conductances and enhanced central excitability in a congenitally deaf (dn/dn) mouse. J Physiol 2004;559:25-33.
11. von Hehn CA, Bhattacharjee A, Kaczmarek LK. Loss of Kv3.1 tonotopicity and alterations in cAMP response element-binding protein signaling in central auditory neurons of hearing impaired mice. J Neurosci 2004;24:1936-40.
12. Ishikawa T, Nakamura Y, Saitoh N, et al. Distinct roles of Kv1 and Kv3 potassium channels at the calyx of Held presynaptic terminal. J Neurosci 2003;23:10445-53.
13. Petersson S, Persson AS, Johansen JE, et al. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. Eur J Neurosci 2003;18:3231-40.
14. Lu Y, Monsivais P, Tempel BL, et al. Activity-dependent regulation of the potassium channel subunits Kv1.1 and Kv3.1. J Comp Neurol 2004;470:93-106.
15. Baguley DM. Mechanisms of tinnitus. Br Med Bull 2002;63:195-212.
16. Kaltenbach JA. Neurophysiologic mechanisms of tinnitus. J Am Acad Audiol 2000;11:125-37.
17. Eggermont JJ, Roberts LE. The neuroscience of tinnitus. Trends Neurosci 2004;27:676-82.
18. Bauer CA. Mechanisms of tinnitus generation. Curr Opin Otolaryngol Head Neck Surg 2004;12:413-7.
19. Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. Am J Otol 1996;17:236-40.
20. Moller AR. Similarities between severe tinnitus and chronic pain. J Am Acad Audiol 2000;11:115-24.
21. Kaltenbach JA, Zacharek MA, Zhang J, et al. Activity in the dorsal cochlear nucleus of hamsters previously tested for tinnitus following intense tone exposure. Neurosci Lett 2004;355:121-5.
22. Chen GD, Jastreboff PJ. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hear Res 1995;82:158-78.
23. Melcher JR, Sigalovsky IS, Guinan JJ Jr., et al. Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol 2000;83:1058-72.
24. Simpson JJ, Davies WE. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci 1999;20:12-8.
25. Reyes SA, Salvi RJ, Burkard RF, et al. Brain imaging of the effects of lidocaine on tinnitus. Hear Res 2002;171:43-50.
26. Perucca E, Jackson P. A controlled study of the suppression of tinnitus by lidocaine infusion: relationship of therapeutic effect with serum lidocaine levels. J Laryngol Otol 1985;99:657-61.
27. Den Hartigh J, Hilders CG, Schoemaker RC, et al. Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration. Clin Pharmacol Ther 1993;54:415-20.
28. Chan VW, Weisbrod MJ, Kaszas Z, et al. Comparison of ropivacaine and lidocaine for intravenous regional anesthesia in volunteers. Anesthesiology 1999;90:1602-8.
29. Baguley DM, Jones S, Wilkins I, et al. The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: a double-blind, placebo-controlled, crossover study. Otol Neurotol 2005;26:169-76.
30. Manabe Y, Yoshida S, Saito H, et al. Effects of lidocaine on salicylate-induced discharge of neurons in the inferior colliculus of the guinea pig. Hear Res 1997;103:192-8.
31. Elliott AA, Harrold JA, Newman JP, et al. Open channel block and open channel destabilization: contrasting effects of phenol, TEA+ and local anaesthetics on Kv1.1 K+ channels. Toxicol Lett 1998;100-101:277-85.
32. Rolf S, Haverkamp W, Borggrefe M, et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol 2000;362:22-31.
33. Gonzalez T, Longobardo M, Caballero R, et al. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels. J Pharmacol Exp Ther 2001;296:573-83.
34. Friederich P, Benzenberg D, Urban BW. Bupivacaine inhibits human neuronal Kv3 channels in SH-SY5Y human neuroblastoma cells. Br J Anaesth 2002;88:864-6.
35. Friederich P, Dilger JP, Isbrandt D, et al. Biophysical properties of Kv3.1 channels in SH-SY5Y human neuroblastoma cells. Receptors Channels 2003;9:387-96.
36. Friederich P, Urban BW. Interaction of intravenous anesthetics with human neuronal potassium currents in relation to clinical concentrations. Anesthesiology 1999;91:1853-60.
37. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
38. Brown NA, Kemp JA, Seabrook GR. Block of human voltage-sensitive Na+ currents in differentiated SH-SY5Y cells by lifarizine. Br J Pharmacol 1994;113:600-6.
39. Armstrong CM. Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injected in squid axons. J Gen Physiol 1969;54:553-75.
40. Nilsson J, Madeja M, Arhem P. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action. Mol Pharmacol 2003;63:1417-29.
41. Urban BW. Current assessment of targets and theories of anaesthesia. Br J Anaesth 2002;89:167-83.
42. Routledge PA, Barchowsky A, Bjornsson TD, et al. Lidocaine plasma protein binding. Clin Pharmacol Ther 1980;27:347-51.
43. Tucker GT, Boyes RN, Bridenbaugh PO, et al. Binding of anilide-type local anesthetics in human plasma: relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology 1973;33:287-303.
44. Friederich P, Urban BW. The inhibition of human neuronal K+ currents by general anesthetic agents is altered by extracellular K. Brain Res Mol Brain Res 1998;60:301-4.
45. Watanabe I, Wang HG, Sutachan JJ, et al. Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism. J Physiol 2003;550:51-66.
46. Yi BA, Minor DL Jr., Lin YF, et al. Controlling potassium channels activities: interplay between the membrane and intracellular factors. Proc Natl Acad Sci USA 2001;98:11016-23.